Blog
Globe Life Q1 Earnings Miss Estimates, Rise Y/Y on Higher Premiums
Globe Life Inc. GL reported first-quarter 2026 net operating income of $3.43 per share, which missed the Zacks Consensus Estimate by 0.9%. The bottom line, however, improved 11.7% year over year
MOH Q1 EPS Tops Estimates on Lower Medical Costs, Membership Declines
Molina Healthcare Inc. MOH reported first-quarter 2026 adjusted earnings per share (EPS) of $2.35, which beat the Zacks Consensus Estimate of $1.57. The bottom line declined 61.3% from the year-ago
Cisco Cashes in on AI Order Momentum: More Upside Ahead in 2026?
Cisco Systems CSCO is witnessing a sharp acceleration in AI-related demand, especially from hyperscalers. AI orders in second-quarter fiscal 2026 increased to $2.1 billion from $1.3 billion in
Southwest Airlines Q1 Earnings Meet Estimates, Revenue Beat
Southwest Airlines Co. (LUV) reported first-quarter of 2026 earnings per share of 45 cents, in line with the Zacks Consensus Estimate and improving from a loss of 13 cents in the year-ago quarter
4 Multiline Insurers to Buy Amid Inflation, Low Interest Rate
DOCN Stock Jumps 104% YTD: Is There More Room to Grow?
DigitalOcean DOCN sits in a favorable demand backdrop as artificial intelligence (AI) inference remains supply-constrained, but the investment case hinges on execution and timing. DOCN shares are
Snap-on Q1 Earnings & Revenues Beat Estimates, Organic Sales Rise 3.4%
Snap-on Inc. SNA reported solid first-quarter 2026 results, wherein the top and bottom lines surpassed the Zacks Consensus Estimate and grew year over year. Results showed ongoing momentum, along
RLI Q1 Earnings Miss Estimates, Investment Income Increases Y/Y
RLI Corp. RLI reported first-quarter 2026 operating earnings of 83 cents per share, which missed the Zacks Consensus Estimate by 2.3%. The bottom line decreased 13.2% from the prior-year quarter.
Packaging Corp. Q1 Earnings Beat Estimates on Pricing and Mix
Packaging Corporation of America PKG posted adjusted earnings of $2.40 per share in the first quarter of 2026, up 3.9% from $2.31 a year ago. The result beat the Zacks Consensus Estimate of $2.17 by
CSX Q1 Earnings Beat Estimates, Revenues Lag, 2026 View Raised
CSX Corporation CSX reported mixed first-quarter 2026 results wherein earnings surpassed the Zacks Consensus Estimate while revenues missed the mark.
Quarterly earnings per share of 43 cents
Dover Q1 Earnings Beat Estimates, Rise Y/Y on Solid Demand
Dover Corporation DOV posted first-quarter fiscal 2026 adjusted earnings of $2.28 per share, up 11.2% from $2.05 a year ago. The figure topped the Zacks Consensus Estimate of $2.27, reflecting a
Nasdaq Q1 Earnings & Revenues Beat Estimates, Dividend Raised
Nasdaq NDAQ posted non-GAAP earnings of 96 cents per share for the first quarter of fiscal 2026, up 22% from 79 cents a year ago. The figure beat the Zacks Consensus Estimate by 3.23%.Net revenues
ExxonMobil Awards Saipem $150M Contract for Longtail Development
Exxon Mobil Corporation XOM has awarded a limited notice to proceed (LNTP) contract to Saipem, an Italian engineering and construction services company, for the Longtail development in the Stabroek
CBRE's Q1 Earnings Beat Estimates on Solid Leasing & Capital Markets
CBRE Group, Inc. CBRE posted first-quarter 2026 core earnings of $1.61 per share, up 80.9% from 89 cents a year ago. The figure beat the Zacks Consensus Estimate of $1.13 by 42.48%.
Quarterly
AMD's Ryzen 9950X3D2 Launch Impact: What's Ahead in Gaming Next?
Advanced Micro Devices AMD yesterday unveiled the Ryzen 9 9950X3D2 Dual Edition, a flagship desktop processor that represents a meaningful leap in its high-performance computing strategy. The launch
AXP Q1 Earnings Beat Estimates on Strong US Consumer Services Unit
American Express Company AXP reported first-quarter 2026 earnings per share (EPS) of $4.28, which surpassed the Zacks Consensus Estimate by 6.2%. The bottom line advanced 18% year over year.
Total
Altimmune Catalysts: 2026 Data Readouts and Financing Risks
Altimmune ALT is building its investment case around pemvidutide, a balanced 1:1 glucagon and glucagon-like peptide-1 dual receptor agonist being developed for metabolic dysfunction-associated
FCX's Q1 Earnings and Revenues Top Estimates on Higher Copper Prices
Freeport-McMoRan Inc. FCX recorded net income of $881 million or 61 cents per share for the first quarter of 2026, up around 150% from $352 million or 24 cents in the year-ago quarter.
Barring
Energy ETFs to Shine Amid Supply Constraints and Elusive Peace Talks
With the lack of progress in renewed diplomatic talks between Washington and Tehran, along with rising tensions over control of the Strait of Hormuz, it appears increasingly likely that oil prices
Rollins' Q1 Earnings Match Estimates, Increase Year Over Year
Rollins, Inc. ROL reported impressive first-quarter 2026 results, with earnings meeting the Zacks Consensus Estimate and revenues beating the same.
ROL’s adjusted earnings per share of 24 cents







